Oxford University to commence human trials on a COVID-19 vaccine
Category: #health  | By Nikita Chaurasia  | Date: 2020-04-17 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Oxford University to commence human trials on a COVID-19 vaccine

The university’s vaccine programme has hired around 510 people to take part in the first trial.

As the deadly coronavirus have paved its way to almost every continent, researchers worldwide are putting in their best to develop an effective vaccine to stop this pandemic. Top scientists at the University of Oxford have recently made some developments, announcing that they are ready to commence a human trial on the potential COVID-19 vaccine.

As per reports, the vaccine has already been tested on animals and have shown promising results, facilitating the commencement of the human trial.

Apparently, alike the Oxford team, hundreds of scientists worldwide are also racing towards developing a Covid-19 jab, which could likely take around 18 months to develop. In fact, over 70 potential jabs are currently in development across the global, claims WHO.

To enable speedy vaccine development, Oxford's vaccine programme has hired around 510 people to take part in the first trial, cite sources.

As per Professor Adrian Hill, a lead researcher, their team is going to commence the human trials in the next week, as they have already tested the vaccine on several animal species.

For the record, the vaccine is developed from chimpanzees that were injected with the coronavirus to produce antibodies which could be used to boost the immune system of humans. Estimates claim that the jab, developed by the clinical teams at Oxford Vaccine Group and the Jenner Institute, could be ready by September.

However, as industry leaders and scientists are trying their best to shorten the time to introduce a vaccine in the market, public health officials claim that it could take a year to 18 months to fully validate any potential vaccine.

Meanwhile, last month, the chief scientific adviser of the UK announce that it could be at least 2021 until an effective vaccine was ready.

Source Credit: https://www.dailystar.co.uk/news/latest-news/uk-university-begins-tests-covid-21874152

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

General Motors passes Ford to become the second-best EV seller in U.S.

General Motors passes Ford to become the second-best EV seller in U.S.

By Nikita Chaurasia

Detroit-based American multinational automaker, General Motors, has reportedly pulled ahead of fellow American rival, Ford Motor, to establish itself as second-biggest seller of all-electric vehicles in the US during the first quarter of 2023. The...

McKinsey commences job cuts focused on non-client serving teams

McKinsey commences job cuts focused on non-client serving teams

By Nikita Chaurasia

McKinsey and Co. a consulting giant entity has decided to start cutting jobs in one of the biggest rounds of layoffs for the company. This is likely to eliminate the jobs of about 2000 employees from work. The layoffs will be focused on support st...

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...